Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Israel

Harel 4B Selected Biomed

+ Add to Watchlist

IL30EQY:IT

3,187.53 ILs 11.53 0.36%

As of 00:59:30 ET on 03/04/2015.

Snapshot for Harel 4B Selected Biomed (IL30EQY)

Year To Date: +18.86% 3-Month: +20.40% 3-Year: +2.55% 52-Week Range: 2,540.33 - 4,971.44
1-Month: +8.75% 1-Year: -35.72% 5-Year: -6.75% Beta vs TA-100: 0.92

Mutual Fund Chart for IL30EQY

No chart data available.
  • IL30EQY:IT 3,187.53
  • 1M
  • 1Y
Interactive IL30EQY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IL30EQY

Harel 4B Selected Biomed is an open-end fund registered in Israel. The objective of the fund is to exceed to TA Biomed Index. The fund primarly invests in Biotechnology and Pharmaceutical equities.

Inception Date: 01-01-1993 Telephone: -
Managers: -
Web Site: -

Fundamentals for IL30EQY

NAV (on 2015-03-04) 3,187.53
Assets (M) (on 2015-01-30) 22.60
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for IL30EQY

No dividends reported

Fees & Expenses for IL30EQY

Front Load -
Back Load -
Current Mgmt Fee 2.51
Redemption Fee -
12b1 Fee -
Expense Ratio 2.94

Top Fund Holdings for IL30EQY

Filing Date: 11/30/2014
Name Position Value % of Total
Mazor Robotics Ltd 77,308 1,586,360 9.704%
Evogene Ltd 42,500 1,546,575 9.460%
Pluristem Therapeutics Inc 154,000 1,530,606 9.362%
Compugen Ltd 57,000 1,527,030 9.341%
Protalix BioTherapeutics Inc 186,000 1,516,272 9.275%
Brainsway Ltd 34,000 1,190,680 7.283%
Kamada Ltd 84,000 1,128,120 6.901%
Clal Biotechnology Industries 235,001 690,432 4.223%
Intec Pharma Ltd 930,000 580,320 3.550%
SPDR S&P Biotech ETF 730 510,475 3.122%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil